Tumefactive multiple sclerosis: the lethal chameleon [PDF]
European Journal of Case Reports in Internal MedicineTumefactive multiple sclerosis (TMS) is a rare variant of multiple sclerosis that presents with a large demyelinating lesion in the central nervous system, accompanied by peripheral ring-like enhancement, perilesional oedema and mass effect.
Ana Carolina Monteiro +6 more
doaj +4 more sources
Tumefactive multiple sclerosis in Taiwan. [PDF]
PLoS ONE, 2013 BACKGROUND: Multiple sclerosis (MS) is less common in Asia, including Taiwan, and some characteristics of MS in Asians differ from those of Caucasians. Tumefactive brain lesion is even rarer in MS patients.
Yi-Chun Kuan +3 more
doaj +5 more sources
Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature [PDF]
Frontiers in Neurology, 2015 We report a case of pathologically confirmed tumefactive multiple sclerosis (MS) followed shortly thereafter by the diagnosis of an oligoastrocytoma.
Esteban eGolombievski +3 more
doaj +4 more sources
Tumefactive Demyelinating Lesion Induced by Infliximab in a Patient With Rheumatoid Arthritis: A Case Report [PDF]
Clinical Case ReportsTumor Necrosis Factor‐alpha (TNF‐α) inhibitors have been successfully used to treat rheumatoid arthritis (RA), psoriatic and ankylosing arthritis, and inflammatory bowel disease.
Shahla Mohammed Saeed Rasul +3 more
doaj +3 more sources
Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers [PDF]
Frontiers in ImmunologyObjectiveWe present a case of multiple tumefactive demyelinating lesions (TDLs) emerging 24 months after the second cycle of alemtuzumab treatment.MethodsA woman with relapsing-remitting multiple sclerosis (MS) discontinued fingolimod treatment due to ...
Neus Rabaneda-Lombarte +5 more
doaj +5 more sources
Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment [PDF]
Neurology, 2012 Fingolimod is an oral sphingosine 1-phosphate receptor modulator that prevents recirculation of lymphocyte subsets from lymph nodes. It decreases the number of relapses, slows the progression of disability, and improves MRI endpoints in patients with relapsing-remitting multiple sclerosis (RRMS).1 Infrequent but specific side effects are bradycardia ...
Linssen, W.H.J.P. +4 more
core +6 more sources
Tumefactive multiple sclerosis. [PDF]
Proc (Bayl Univ Med Cent)Tumefactive multiple sclerosis (MS) is a subtype of atypical and rare MS that presents with tumor-like lesions in the central nervous system. The lesions may demonstrate a mass effect, edema, with ring enhancement. They can be mistaken for brain tumors or brain abscesses radiologically and clinically.
Tosunoğlu B +4 more
europepmc +4 more sources
Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities. [PDF]
Cureus, 2023 Tumefactive multiple sclerosis comprises a rare subset of multiple sclerosis that often poses a diagnostic challenge to physicians. It is unique in its presentation as a solitary lesion, usually larger than 2 cm, with surrounding vasogenic edema, commonly mimicking a primary intracranial malignancy.
ElSaygh J +4 more
europepmc +3 more sources
Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal [PDF]
Frontiers in Neurology, 2021 Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid adverse events.
Valeria Koska +8 more
doaj +2 more sources
A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis [PDF]
Case Reports in Neurological Medicine, 2018 Tumefactive Multiple Sclerosis (TMS) is a rare variant with 1 per 1000 cases of MS and 3 per million cases per year. TMS can mimic clinical and radiological features of a neoplasm, infarction, or abscess and therefore can be diagnostically challenging ...
Ramy Mando +3 more
doaj +2 more sources